(Q26849602)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

0 references

title

Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3 references

23 March 2019

21 March 2019

1 July 2020

RNA virus infectious disease

1 reference

1 July 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Mazen Noureddin

series ordinal

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

1 January 2014

4 references

23 March 2019

21 March 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 July 2020

Current gastroenterology reports

5 references

23 March 2019

21 March 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 July 2020

16

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

365

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

2 March 2020

copyright license

start time

30 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Development and evaluation of a baseline-event-anticipation score for hepatitis delta

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Seroprevalence of HDV infection in HBsAg positive population in Ismailia, Egypt

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

An update on HDV: virology, pathogenesis and treatment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

A re-assessment of the epidemiology and patient characteristics of hepatitis D virus infection in inner city London.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatitis D virus infection in the Western Brazilian Amazon - far from a vanishing disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Treatment options for hepatitis delta virus infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Treatment of chronic delta hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Clinical features of hepatitis D.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatitis delta virus diagnosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Epidemiology of hepatitis D.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Viroids and hepatitis delta virus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Highly endemic hepatitis B infection in rural Vietnam.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Delta hepatitis: an update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Denying the wolf access to sheep's clothing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatitis delta virus as a global health problem.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Hepatitis D virus in Victoria 2000-2009.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Epidemiology of hepatitis D in patients infected with hepatitis B virus in bucharest: a cross-sectional study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Ribavirin treatment for chronic hepatitis D: a pilot study.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Identification of a prenylation site in delta virus large antigen

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Famciclovir treatment of chronic delta hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Chronic hepatitis D at a standstill: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918112

Lamivudine for chronic delta hepatitis

28 November 2018

1 reference

12 December 2020

Hepatitis delta virus

1 reference

12 December 2020

Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months

1 reference

12 December 2020

Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis

1 reference

12 December 2020

Peginterferon plus adefovir versus either drug alone for hepatitis delta

1 reference

12 December 2020

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

12 December 2020

Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.

1 reference

https://api.crossref.org/works/10.1007%2FS11894-013-0365-X

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1007/S11894-013-0365-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 March 2020

0 references

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24293018%20AND%20SRC:MED&resulttype=core&format=json